Here are some of the media releases from this amazing conference.
Richard Sullivan is Professor of Cancer & Global Health at Kings College London (KCL), and is the director of the Institute of Cancer Policy. He qualified in medicine, trained in surgery (urology), and gained his PhD in cell signalling. Sullivan was clinical director of Cancer Research UK between 1999 and 2008. Following a period at the London School of Economics working on complex healthcare systems, he moved to KCL in 2011. His research programmes focus on global cancer policy and conflict & health. Born in Yemen, Sullivan is employed in high conflict areas including Syria, Libya, Sierra Leone, Lebanon, and the narco-zones of Mexico, to assess medical needs and how to deliver treatment for cancer and other diseases. He is in Wellington this week for the University of Otago's Cancer Care at a Crossroads, where he's given speeches on global challenges in cancer control and innovations in oncology. Read more and listen here.
Some cancer sufferers are spending large sums of money on expensive drugs that will not extend their life, a specialist says.
Professor Richard Sullivan, the director of the Institute of Cancer Policy at Kings College in London, has been in New Zealand for a conference.
He said many of the most expensive cancer drugs simply did not do what they said they would.
For example, some could shrink the cancer itself but do nothing to extend the life of the patient.
"Some drugs are coming with enormous uncertainty about what sort of benefit they really deliver to patients ... but huge price tags.
"Countries and people are being asked to pay a great deal of money for the unknown and a lot of that unknown doesn't pan out.
"When we look backwards over sort of two or three years we discover the drugs actually don't work." Read more and listen to the interview here.